Written by CannIntelligence || 3rd March 2021 || Market data |
CBD-Intel’s quarterly market size database is your one-stop source for essential information on the CBD market. Data includes market size estimates for various product categories across two separate market development scenarios ...
This week's regulatory news in brief includes updates from Germany, Iceland, Norway, the UK, the US, Colombia, Ghana, Japan, Morocco, Pakistan and Thailand ...
Written by CannIntelligence || 26th February 2021 || Blogs |
There is a chance that enforcement priorities could change under new appointments to the Federal Trade Commission (FTC) by the Biden administration. Two commissioners – one of which is staying on to work as part of the Republican minority...
Written by CannIntelligence || 26th February 2021 || News analysis |
CBD-infused gin manufacturer Silent Pool remains defiant after drinks industry regulatory body the Portman Group ruled that its Colorado High product was in violation of its code ...
Jon Bruford, CBD-Intel's podcasts editor, is joined by the CEO & co-founder of the Greenheart CBD Ltd, Mark Canavan, an Irish-owned company that produces and sells CBD oil made from Irish-grown hemp ...
Written by CannIntelligence || 18th February 2021 || Blogs |
The Home Office has not changed licensing requirements for importers of CBD into the UK. The minister for policing, Christopher “Kit” Malthouse, has requested an updated recommendation from the Advisory Council on the Misuse of Drugs (ACMD) on acceptable...
Our host for today’s podcast is Jon Bruford, a copy editor at CBD-Intel, who will be joined by CBD-Intel junior legal analyst Elsa Carrasco, who discusses the current regulatory framework in place for CBD and cannabis in the...
Written by CannIntelligence || 12th February 2021 || Blogs |
The European Food Safety Authority (EFSA) has stated that it is in contact with other similar agencies such as the Food Standards Agency (FSA) in the UK, but only specified that it would not treat applications that had been approved...
Written by CannIntelligence || 10th February 2021 || News analysis |
US president Joe Biden’s appointees to a number of influential positions in the new administration give reason for optimism within the hemp and cannabis sector ...
Written by CannIntelligence || 5th February 2021 || Blogs |
The Portman Group’s first decision on a complaint regarding a CBD product has gone largely unreported but could have a very significant impact on that part of the market. The voluntary alcohol industry regulator has said it is bringing...
CBD-Intel’s managing director, Tim Phillips, recently presented on the major global factors seen in the CBD industry in 2020, key pricing and product evolution throughout the year, and what to expect in 2021 during the GCI Virtual Summit....
Written by CannIntelligence || 28th January 2021 || Blogs |
The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market....
Written by CannIntelligence || 28th January 2021 || News analysis |
Two German parliamentary groups have submitted a joint initiative to remove industrial hemp from the Narcotics Act and raise the THC limit from 0.2% to at least 0.6% ...
Written by CannIntelligence || 27th January 2021 || News analysis |
British CBD brands are suspending shipping to the EU, European customers are hit by unexpected import fees, and UK entrepreneurs are struggling to establish their start-ups, as Brexit regulations cause chaos ...
Written by CannIntelligence || 25th January 2021 || News analysis |
Dutch officials have granted a six-month reprieve to find a solution to an omission in the Brexit negotiations that threatens to deprive British epilepsy patients of access to cannabis-based medicines ...
Written by CannIntelligence || 22nd January 2021 || Blogs |
The top-line answer is that it is wholly neither. There are elements of both in any position taken on the news. BAT’s entrance into the market with its vaping product under the Vuse brand (coming in three flavours – mint, mango...
This week's regulatory news in brief includes updates from Bosnia and Herzegovina, France, Germany, Ireland, Italy, Netherlands, Poland, the US, Brazil, Costa Rica, Thailand and...
Written by CannIntelligence || 15th January 2021 || Blogs |
Canopy Growth’s quick action – filing a suit against GW Pharmaceuticals the day the patent was issued – coupled with the short time-frame for validity has left many worried that the company could go on an enforcement hunt...
A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the...
Unlike psychoactive cannabis, cultivation and processing of industrial hemp is not allowed in North Macedonia – however this may change. This report offers an overview of the current and likely future legal framework ...
Written by CannIntelligence || 8th January 2021 || Blogs |
President elect Joe Biden still looks to be somewhat reluctant to too closely embrace cannabis reform as an issue. But effective control of the senate through victories by Raphael Warnock and Jon Ossoff in special run-off elections in...
Written by CannIntelligence || 4th January 2021 || News analysis |
Further CBD regulations in the US could be based on rules proposed in the state of New York, it has been suggested – especially crucial definitions for some key terms ...
Written by CannIntelligence || 1st January 2021 || News analysis |
Marketers recommend the use of gift cards, along with discounts on higher strength and quality blends to drive new consumer growth in January and to convert new customers into repeat customers ...
Written by CannIntelligence || 31st December 2020 || News analysis |
Multiple jurisdictions are planning significant legislation on both CBD and hemp-related matters, but it seems regulation in 2021 could be defined as much by what doesn’t happen as by the progress made ...
Written by CannIntelligence || 30th December 2020 || News analysis |
Efforts to supply the first CBD product to Brazil’s public healthcare system will have to wait a while longer – and there is some dispute between the institute preparing to produce it and the sponsors of a Congress...
Written by CannIntelligence || 29th December 2020 || News analysis |
The US Food and Drug Administration (FDA) is still working on a plan to standardise a baseline level of regulation for CBD in dietary supplements, food and drinks – but many in the industry and at state level...
This week's regulatory news in brief includes updates from the UE, Iceland, Ireland, Italy, Lithuania, the UK, Ukraine, the US, Australia and Thailand ...
This week's regulatory news in brief includes updates from Belgium, France, Ireland, Italy, Netherlands, Switzerland, Bermuda, the British Virgin Islands, Canada, Guam, the US, Australia, Brazil, Philippines, Thailand and Uzbekistan ...
Written by CannIntelligence || 18th December 2020 || Blogs |
It seems many of the firms CBD-Intel has talked to see a similar story for January sales, focused on resolutions or upticks in health and wellness – as was predicted for the holidays sales period stretching from Black...
Written by CannIntelligence || 18th December 2020 || News analysis |
Cannabis legalisation is so far away in Russia that the plant is now considered a national security threat, according to provisions of the new state strategy for Anti-Drug...
Written by CannIntelligence || 17th December 2020 || News analysis |
Zimbabwe’s minister of finance and economic development, Mthuli Ncube, has proposed wide-ranging and hugely ambitious cannabis levies in the country, starting next year ...
Written by CannIntelligence || 17th December 2020 || News analysis |
The Italian Customs Agency is trying to widen its jurisdiction by proposing including the sale of CBD hemp flowers within the state monopoly. Others have similar ideas ...
Written by CannIntelligence || 16th December 2020 || News analysis |
A proposed amendment to Polish law would ban the sale of CBD products through vending machines – but one company using that distribution method does not see any reason to stop just yet ...
CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place ...
This week's regulatory news in brief includes updates from North Macedonia, Switzerland, Mexico, the US, British Virgin Islands, Ecuador, Israel, New Zealand and Thailand ...
Written by CannIntelligence || 11th December 2020 || News analysis |
The European Parliament will have a united position on hemp-related issues during the ongoing tripartite negotiations, which must be concluded by the end of March ...
Written by CannIntelligence || 11th December 2020 || Blogs |
The Court of Justice of the European Union’s (CJEU) decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. A...
This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis ...
Cannabis, THC and CBN are controlled substances in Ireland under the Misuse of Drugs Act, but CBD and CBG are not. This report offers an overview of the current regime in Ireland ...
Written by CannIntelligence || 8th December 2020 || News analysis |
While solid research explaining the science behind CBD remains lacking as the market continues to grow, some bad actors in the industry are making false scientific claims for their products ...
This week's regulatory news in brief includes updates from Belgium, Cyprus, the EU, Denmark, France, Ireland, Italy, Slovakia, Spain, the US, Colombia, Costa Rica, New Zealand and Thailand ...
Written by CannIntelligence || 4th December 2020 || Blogs |
The announcement is a full reversal from the EC on a position that many found surprising in the first place. It marks a stellar period for the regulation of CBD and other cannabinoids with major decisions in their...